Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Shamol
    Junior Member
    • Sep 2016
    • 5

    #1

    Sample preparation and library information for HPV cervical swabs

    Hello all,

    My project involves sequencing the complete genomes of local Human Papillomavirus isolates. The isolates were collected from three kinds of samples:

    1. Tissue samples from cancer patients
    2. Cervical swabs from cancer patients
    3. Cervical swabs from asymptomatic HPV careers

    Most of the samples were of type 3 above. I have been trying to sequence some of these genomes using the PCR amplification followed by Sanger sequencing, but very, very few of the samples could be amplified to begin with (presumably because the DNA concentration especially in the swab samples were relatively low). My supervisor suggested I look into NGS as an alternative due to its high resolution.

    I'm from Bangladesh, and this technology is virtually unheard of here. I've been spending the past two weeks poring over papers on NGS and applications thereof in virology. I've picked up the general skeletal protocol, but there's only so much you can learn from papers and at some point you need directed expert advice. I'm currently looking for guidance on these three issues related sample preparation:

    1. Since the samples I'm working with contain host DNA, should I have a physical enrichment process (e.g. centrifugation and/or DNAse/RNAse treatment to remove unprotected nucleic acid) incorporated in the sample preparation?

    2. Given the low quantity of DNA in my samples, there's a chance that the amount of viral DNA would be very low. Is there a particularly high resolution library preparation service which can solve this problem? If so, what would be lowest quantity of DNA required?

    3. In the cancerous tissue samples (and cancerous cervical swabs), the HPV genome stays integrated into the host (human) genome, precluding the possibility of physical enrichment. How would the sample preparation work in this case?

    Thanks in advance for the replies, I'd appreciate them greatly.
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    Your problem is not the sequencing method; it's the inability to amplify your samples by PCR. NGS will not solve that problem, b/c it also requires PCR amplification of low abundance DNA samples. You need to troubleshoot the PCR protocol.

    Comment

    • Shamol
      Junior Member
      • Sep 2016
      • 5

      #3
      Thanks for your reply. Are you saying the problem I've been having with trying to amplify DNA with PCR (probably due to low quality of DNA in the original samples) will be there in an NGS platform as well? The whole reason I'm considering NGS is because my supervisor thought this could bypass the need for PCR, which has been really inconsistent with the samples we've been working with. Thanks again for the replies in advance.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      44 views
      0 reactions
      Last Post SEQadmin2  
      Working...